Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > 60 Minutes ; - ) "EUA" is one thing FDA "Expanded Use"...

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Apr 12, 2021 12:41pm

188 Views

Post# 32977881

60 Minutes ; - ) "EUA" is one thing FDA "Expanded Use"...

quite another....see our "#12 horse with No-name" CV19 trial here in the US as part of a full approval for CV19 by way of Expanded Access. Couple this with positives released in EU by KOL's and Estor and you got yurself a meal ... maybe a grilled chesse given today is a special day.

TIC TOC ; - )

https://www.cbsnews.com/news/last-pandemic-science-military-60-minutes-2021-04-11/

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale